|
US5994341A
(en)
*
|
1993-07-19 |
1999-11-30 |
Angiogenesis Technologies, Inc. |
Anti-angiogenic Compositions and methods for the treatment of arthritis
|
|
DE69403966T3
(de)
|
1993-07-19 |
2008-04-17 |
Angiotech Pharmaceuticals, Inc., Vancouver |
Anti-angiogene mittel und verfahren zu deren verwendung
|
|
US5443505A
(en)
*
|
1993-11-15 |
1995-08-22 |
Oculex Pharmaceuticals, Inc. |
Biocompatible ocular implants
|
|
US5620013A
(en)
*
|
1994-10-21 |
1997-04-15 |
American Cyanamid Company |
Method for destroying residual lens epithelial cells
|
|
US5869079A
(en)
*
|
1995-06-02 |
1999-02-09 |
Oculex Pharmaceuticals, Inc. |
Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
|
|
US20060280774A1
(en)
*
|
1995-06-02 |
2006-12-14 |
Allergan, Inc. |
Compositions and methods for treating glaucoma
|
|
US5904144A
(en)
*
|
1996-03-22 |
1999-05-18 |
Cytotherapeutics, Inc. |
Method for treating ophthalmic diseases
|
|
US6299895B1
(en)
|
1997-03-24 |
2001-10-09 |
Neurotech S.A. |
Device and method for treating ophthalmic diseases
|
|
US6063370A
(en)
*
|
1996-04-05 |
2000-05-16 |
The Board Of Trustees Of The University Of Illinois |
Macromolecular complexes for drug delivery
|
|
US5935599A
(en)
*
|
1996-10-28 |
1999-08-10 |
The Board Of Trustees Of The University Of Illinois |
Polymer-associated liposomes for drug delivery and method of manufacturing the same
|
|
EP1003569B1
(de)
*
|
1997-08-11 |
2004-10-20 |
Allergan, Inc. |
Steriles retinoid enthaltendes biodegradierbares implantat mit verbesserter biocompatibilität und verfahren zu dessen herstellung
|
|
US6991650B2
(en)
|
1997-10-08 |
2006-01-31 |
Refocus Ocular, Inc. |
Scleral expansion device having duck bill
|
|
US6007578A
(en)
|
1997-10-08 |
1999-12-28 |
Ras Holding Corp |
Scleral prosthesis for treatment of presbyopia and other eye disorders
|
|
RU2120254C1
(ru)
*
|
1997-10-28 |
1998-10-20 |
Институт нефтехимического синтеза им.А.В.Топчиева РАН |
Имплантат для реконструктивно-восстановительной хирургии
|
|
RU2119780C1
(ru)
*
|
1997-10-28 |
1998-10-10 |
Институт нефтехимического синтеза им.А.В.Топчиева РАН |
Имплантат для реконструктивно-восстановительной хирургии
|
|
PT1019111E
(pt)
|
1998-04-27 |
2002-10-31 |
Surmodics Inc |
Revestimento que liberta um agente bioactivo
|
|
AU4847999A
(en)
*
|
1998-06-29 |
2000-01-17 |
George W. Rozakis |
Antioxidant intraocular lens
|
|
US6024719A
(en)
*
|
1998-07-06 |
2000-02-15 |
Morris; Robert E |
Method and apparatus for performing surgery inside the human retina using fluidic internal limiting membrane (ILM) seperation (FILMS)
|
|
US6378526B1
(en)
|
1998-08-03 |
2002-04-30 |
Insite Vision, Incorporated |
Methods of ophthalmic administration
|
|
US6309374B1
(en)
|
1998-08-03 |
2001-10-30 |
Insite Vision Incorporated |
Injection apparatus and method of using same
|
|
FR2787991B1
(fr)
*
|
1998-12-31 |
2001-05-25 |
Medicale De Prec S M P Sa Soc |
Dispositif pour traiter la presbytie ou autre affection oculaire
|
|
JP2002534139A
(ja)
*
|
1999-01-05 |
2002-10-15 |
マサチューセッツ・アイ・アンド・イア・インファーマリー |
網膜と脈絡膜への経強膜徐放性薬剤標的送達
|
|
US6113638A
(en)
*
|
1999-02-26 |
2000-09-05 |
Williams; Lytton A. |
Method and apparatus for intervertebral implant anchorage
|
|
US6217895B1
(en)
*
|
1999-03-22 |
2001-04-17 |
Control Delivery Systems |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
|
US20040121014A1
(en)
*
|
1999-03-22 |
2004-06-24 |
Control Delivery Systems, Inc. |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
|
MXPA01010829A
(es)
|
1999-04-26 |
2003-06-30 |
Gmp Vision Solutions Inc |
Dispositivo de trabe culotomia y metodo para el tratamiento del glaucoma.
|
|
US6699210B2
(en)
*
|
1999-04-27 |
2004-03-02 |
The Arizona Board Of Regents |
Glaucoma shunt and a method of making and surgically implanting the same
|
|
AU5599300A
(en)
|
1999-06-07 |
2000-12-28 |
Ras Holding Corporation |
Improved scleral prosthesis for treatment of presbyopia and other eye disorders
|
|
US7008396B1
(en)
|
1999-09-03 |
2006-03-07 |
Restorvision, Inc. |
Ophthalmic device and method of manufacture and use
|
|
DE19947711B4
(de)
*
|
1999-10-04 |
2004-02-12 |
Schrage, Norbert, Priv. Doz. Dr.med. |
Implantat zum Eisatz in der Glaukomtherapie
|
|
US7943162B2
(en)
*
|
1999-10-21 |
2011-05-17 |
Alcon, Inc. |
Drug delivery device
|
|
AU775149B2
(en)
|
1999-10-21 |
2004-07-22 |
Alcon Inc. |
Sub-tenon drug delivery
|
|
US6416777B1
(en)
*
|
1999-10-21 |
2002-07-09 |
Alcon Universal Ltd. |
Ophthalmic drug delivery device
|
|
TR200201047T2
(tr)
|
1999-10-21 |
2002-07-22 |
Alcon, Inc. |
İlaç verme vasıtası.
|
|
US6331313B1
(en)
|
1999-10-22 |
2001-12-18 |
Oculex Pharmaceticals, Inc. |
Controlled-release biocompatible ocular drug delivery implant devices and methods
|
|
US6852688B2
(en)
|
2000-03-10 |
2005-02-08 |
University Of Florida |
Compositions for treating diabetic retinopathy and methods of using same
|
|
US20050277864A1
(en)
*
|
2000-04-14 |
2005-12-15 |
David Haffner |
Injectable gel implant for glaucoma treatment
|
|
US7708711B2
(en)
|
2000-04-14 |
2010-05-04 |
Glaukos Corporation |
Ocular implant with therapeutic agents and methods thereof
|
|
US6638239B1
(en)
|
2000-04-14 |
2003-10-28 |
Glaukos Corporation |
Apparatus and method for treating glaucoma
|
|
US20040111050A1
(en)
*
|
2000-04-14 |
2004-06-10 |
Gregory Smedley |
Implantable ocular pump to reduce intraocular pressure
|
|
US7867186B2
(en)
|
2002-04-08 |
2011-01-11 |
Glaukos Corporation |
Devices and methods for treatment of ocular disorders
|
|
US20020143284A1
(en)
*
|
2001-04-03 |
2002-10-03 |
Hosheng Tu |
Drug-releasing trabecular implant for glaucoma treatment
|
|
US20050049578A1
(en)
*
|
2000-04-14 |
2005-03-03 |
Hosheng Tu |
Implantable ocular pump to reduce intraocular pressure
|
|
US6375972B1
(en)
|
2000-04-26 |
2002-04-23 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
|
|
US6417237B1
(en)
|
2000-06-08 |
2002-07-09 |
The Board Of Trustees Of The University Of Illinois |
Macromolecular drug complexes and compositions containing the same
|
|
US6692759B1
(en)
*
|
2000-06-28 |
2004-02-17 |
The Regents Of The University Of California |
Methods for preparing and using implantable substance delivery devices
|
|
US6726918B1
(en)
|
2000-07-05 |
2004-04-27 |
Oculex Pharmaceuticals, Inc. |
Methods for treating inflammation-mediated conditions of the eye
|
|
EP1637126B1
(de)
*
|
2000-07-05 |
2016-12-14 |
Allergan, Inc. |
Verfahren zur Behandlung von entzündungsbedingten Zuständen der Augen
|
|
PE20020146A1
(es)
*
|
2000-07-13 |
2002-03-31 |
Upjohn Co |
Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
|
|
ATE547080T1
(de)
*
|
2000-08-30 |
2012-03-15 |
Univ Johns Hopkins |
Vorrichtungen zur intraokularen arzneimittelabgabe
|
|
AR031135A1
(es)
|
2000-10-10 |
2003-09-10 |
Upjohn Co |
Composiciones de antibiotico topico para el tratamiento de infecciones oculares
|
|
US20030082183A1
(en)
*
|
2000-11-01 |
2003-05-01 |
Wheeler Larry A. |
Methods and compositions for treatment of ocular neovascularization and neural injury
|
|
WO2002058730A2
(en)
*
|
2000-11-01 |
2002-08-01 |
Allergan, Inc. |
Compositions for treatment of ocular neovascularization
|
|
US6534693B2
(en)
*
|
2000-11-06 |
2003-03-18 |
Afmedica, Inc. |
Surgically implanted devices having reduced scar tissue formation
|
|
US6699493B2
(en)
|
2000-11-29 |
2004-03-02 |
Oculex Pharmaceuticals, Inc. |
Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
|
|
DE60219607T2
(de)
*
|
2001-01-09 |
2007-12-27 |
Microchips, Inc., Bedford |
Flexible mikrochip-vorrichtungen zur ophthalmologischen und anderen applikation
|
|
US6713081B2
(en)
*
|
2001-03-15 |
2004-03-30 |
The United States Of America As Represented By The Department Of Health And Human Services |
Ocular therapeutic agent delivery devices and methods for making and using such devices
|
|
US7431710B2
(en)
|
2002-04-08 |
2008-10-07 |
Glaukos Corporation |
Ocular implants with anchors and methods thereof
|
|
ES2304438T3
(es)
|
2001-04-07 |
2008-10-16 |
Glaukos Corporation |
Stent de glaucoma para el tratamiento del glaucoma.
|
|
US7488303B1
(en)
*
|
2002-09-21 |
2009-02-10 |
Glaukos Corporation |
Ocular implant with anchor and multiple openings
|
|
US6981958B1
(en)
*
|
2001-05-02 |
2006-01-03 |
Glaukos Corporation |
Implant with pressure sensor for glaucoma treatment
|
|
US7795218B2
(en)
|
2001-04-12 |
2010-09-14 |
Bioaxone Therapeutique Inc. |
ADP-ribosyl transferase fusion variant proteins
|
|
US20040022853A1
(en)
*
|
2001-04-26 |
2004-02-05 |
Control Delivery Systems, Inc. |
Polymer-based, sustained release drug delivery system
|
|
US7678065B2
(en)
|
2001-05-02 |
2010-03-16 |
Glaukos Corporation |
Implant with intraocular pressure sensor for glaucoma treatment
|
|
US7094225B2
(en)
|
2001-05-03 |
2006-08-22 |
Glaukos Corporation |
Medical device and methods of use of glaucoma treatment
|
|
WO2002089767A1
(en)
|
2001-05-03 |
2002-11-14 |
Massachusetts Eye And Ear Infirmary |
Implantable drug delivery device and use thereof
|
|
US20060241750A1
(en)
*
|
2001-05-22 |
2006-10-26 |
Ras Holding Corp |
Scleral expansion device having duck bill
|
|
EP2316394B1
(de)
*
|
2001-06-12 |
2016-11-23 |
The Johns Hopkins University |
Reservoirvorrichtung für die intraokulare Arzneimittelabgabe
|
|
US7592016B2
(en)
*
|
2001-06-28 |
2009-09-22 |
Regents Of The University Of California |
Methods for preparing and using implantable substance delivery devices
|
|
DE10133870A1
(de)
*
|
2001-07-12 |
2003-02-06 |
Chris P Lohmann |
Ophthalmisches Mittel, Verwendung von EGF zur Behandlung von Dry Eye-Syndrom und Insert zur Verabreichung von EGF am Auge
|
|
PT1385452E
(pt)
*
|
2001-07-23 |
2006-12-29 |
Alcon Inc |
Dispositivo de administração de fármacos oftálmicos
|
|
DE60217679T2
(de)
|
2001-07-23 |
2007-10-25 |
Alcon Inc. |
Vorrichtung zur freisetzung eines ophthalmischen arzneimittels
|
|
US8267995B2
(en)
*
|
2001-08-03 |
2012-09-18 |
David Castillejos |
Method and intra sclera implant for treatment of glaucoma and presbyopia
|
|
US7331984B2
(en)
|
2001-08-28 |
2008-02-19 |
Glaukos Corporation |
Glaucoma stent for treating glaucoma and methods of use
|
|
RU2311892C2
(ru)
*
|
2001-08-29 |
2007-12-10 |
КАРВАЛХО Рикардо А. П. ДЕ |
Имплантируемая и герметизируемая система для однонаправленной доставки терапевтических препаратов в ткани
|
|
GB0122318D0
(en)
*
|
2001-09-14 |
2001-11-07 |
Novartis Ag |
Organic compounds
|
|
IN2014DN10834A
(de)
*
|
2001-09-17 |
2015-09-04 |
Psivida Inc |
|
|
DE60218336T2
(de)
*
|
2001-10-30 |
2007-10-31 |
Eyeborn (Proprietary) Ltd., Brummeria |
Orbitalimplantat
|
|
FR2833493B1
(fr)
*
|
2001-12-18 |
2005-09-23 |
Ioltechnologie Production |
Forme galenique solide et soluble pour l'administration occulaire de principes actifs et procede de fabrication d'un insert ophtalmique solide et soluble
|
|
US20030180294A1
(en)
*
|
2002-02-22 |
2003-09-25 |
Devries Gerald W. |
Methods of extending corneal graft survival
|
|
US7186232B1
(en)
|
2002-03-07 |
2007-03-06 |
Glaukoa Corporation |
Fluid infusion methods for glaucoma treatment
|
|
EP1482914B1
(de)
*
|
2002-03-11 |
2015-04-22 |
Novartis AG |
Implantierbare arzneimittelabgabevorrichtung fürs auge
|
|
US7951155B2
(en)
|
2002-03-15 |
2011-05-31 |
Glaukos Corporation |
Combined treatment for cataract and glaucoma treatment
|
|
US20040147870A1
(en)
*
|
2002-04-08 |
2004-07-29 |
Burns Thomas W. |
Glaucoma treatment kit
|
|
US9301875B2
(en)
|
2002-04-08 |
2016-04-05 |
Glaukos Corporation |
Ocular disorder treatment implants with multiple opening
|
|
US20040024345A1
(en)
*
|
2002-04-19 |
2004-02-05 |
Morteza Gharib |
Glaucoma implant with valveless flow bias
|
|
AU2003217531A1
(en)
*
|
2002-05-02 |
2003-11-17 |
Massachusetts Eye And Ear Infirmary |
Ocular drug delivery systems and use thereof
|
|
BR0309844A
(pt)
*
|
2002-05-07 |
2005-02-15 |
Control Delivery Sys Inc |
Processos para formação de um dispositivo para a distribuição de droga
|
|
US8871241B2
(en)
*
|
2002-05-07 |
2014-10-28 |
Psivida Us, Inc. |
Injectable sustained release delivery devices
|
|
US7097850B2
(en)
*
|
2002-06-18 |
2006-08-29 |
Surmodics, Inc. |
Bioactive agent release coating and controlled humidity method
|
|
DE60310078T2
(de)
*
|
2002-07-09 |
2007-06-06 |
AECC ENTERPRISES LTD., Bournemouth |
Verfahren zur bilddarstellung der relativen bewegung von skelettsegmenten
|
|
MXPA05000632A
(es)
*
|
2002-07-15 |
2005-03-31 |
Alcon Inc |
Composiciones para implante farmaceuticas, lipofilas, no polimericas para uso intraocular.
|
|
US20070184089A1
(en)
*
|
2002-07-15 |
2007-08-09 |
Alcon, Inc. |
Non-Polymeric Lipophilic Pharmaceutical Implant Compositions for Intraocular Use
|
|
US20070027537A1
(en)
*
|
2002-08-02 |
2007-02-01 |
David Castillejos |
Method and intra-sclera implant for treatment of glaucoma and presbyopia
|
|
EP1539066B1
(de)
*
|
2002-09-17 |
2012-11-07 |
Iscience Surgical Corporation |
Gerät zur chirurgischen umleitung von wässrigen körperflüssigkeiten
|
|
US6899717B2
(en)
*
|
2002-09-18 |
2005-05-31 |
Allergan, Inc. |
Methods and apparatus for delivery of ocular implants
|
|
WO2004026106A2
(en)
*
|
2002-09-18 |
2004-04-01 |
Allergan, Inc. |
Methods and apparatus for delivery of ocular implants
|
|
US7468065B2
(en)
|
2002-09-18 |
2008-12-23 |
Allergan, Inc. |
Apparatus for delivery of ocular implants
|
|
US20050203542A1
(en)
*
|
2002-09-18 |
2005-09-15 |
Allergan, Inc. |
Apparatus for delivery of ocular implants with reduced incidence of ocular adverse events
|
|
AU2003301347A1
(en)
*
|
2002-10-17 |
2004-05-04 |
Control Delivery Systems, Inc. |
Methods for monitoring treatment of disease
|
|
US20040111144A1
(en)
*
|
2002-12-06 |
2004-06-10 |
Lawin Laurie R. |
Barriers for polymeric coatings
|
|
AU2003286321A1
(en)
*
|
2002-12-19 |
2004-07-14 |
Pfizer Inc. |
2-(1h-indazol-6-ylamino)-benzamide compounds as protein kinases inhibitors useful for the treatment of ophtalmic diseases
|
|
US20060166879A1
(en)
*
|
2002-12-20 |
2006-07-27 |
Chakshu Research Inc |
Treatment of conditions associated with the presence of macromolecular aggregates, particularly ophthalmic disorders
|
|
US20060172972A1
(en)
*
|
2002-12-20 |
2006-08-03 |
Chakshu Research Inc |
Formulation and method for administration of ophthalmologically active agents
|
|
WO2004058289A1
(en)
*
|
2002-12-20 |
2004-07-15 |
Chakshu Research, Inc. |
Ophthalmic formulation for the prevention and treatment of ocular conditions
|
|
US20060177430A1
(en)
*
|
2002-12-20 |
2006-08-10 |
Chakshu Research Inc |
Treatment of ocular disorders with ophthalmic formulations containing methylsulfonylmethane as a transport enhancer
|
|
US8185209B2
(en)
*
|
2003-01-03 |
2012-05-22 |
Board Of Trustees Operating Michigan State University |
Methods to extend vision to infrared wavelengths
|
|
US20040137059A1
(en)
|
2003-01-09 |
2004-07-15 |
Thierry Nivaggioli |
Biodegradable ocular implant
|
|
US20050048099A1
(en)
*
|
2003-01-09 |
2005-03-03 |
Allergan, Inc. |
Ocular implant made by a double extrusion process
|
|
WO2004073551A2
(en)
*
|
2003-02-18 |
2004-09-02 |
Massachusetts Eye And Ear Infirmary |
Transscleral drug delivery device and related methods
|
|
US9216106B2
(en)
|
2003-04-09 |
2015-12-22 |
Directcontact Llc |
Device and method for the delivery of drugs for the treatment of posterior segment disease
|
|
US8246974B2
(en)
|
2003-05-02 |
2012-08-21 |
Surmodics, Inc. |
Medical devices and methods for producing the same
|
|
US8021680B2
(en)
*
|
2003-05-02 |
2011-09-20 |
Surmodics, Inc. |
Controlled release bioactive agent delivery device
|
|
US20040225250A1
(en)
|
2003-05-05 |
2004-11-11 |
Michael Yablonski |
Internal shunt and method for treating glaucoma
|
|
US7589107B2
(en)
|
2003-05-19 |
2009-09-15 |
Othera Holding, Inc. |
Amelioration of vitrectomy-induced cataracts
|
|
WO2005009297A1
(en)
*
|
2003-07-10 |
2005-02-03 |
Alcon, Inc. |
Ophthalmic drug delivery device
|
|
US20050009910A1
(en)
*
|
2003-07-10 |
2005-01-13 |
Allergan, Inc. |
Delivery of an active drug to the posterior part of the eye via subconjunctival or periocular delivery of a prodrug
|
|
ES2391975T3
(es)
*
|
2003-07-25 |
2012-12-03 |
Genvec, Inc. |
Vacunas a base de vector adenovírico
|
|
JP2007505932A
(ja)
|
2003-09-18 |
2007-03-15 |
マクサイト， インコーポレイテッド |
経強膜送達
|
|
WO2005048873A2
(en)
*
|
2003-11-12 |
2005-06-02 |
Alcon, Inc. |
Kit for administration of a drug
|
|
US20060141049A1
(en)
*
|
2003-11-12 |
2006-06-29 |
Allergan, Inc. |
Triamcinolone compositions for intravitreal administration to treat ocular conditions
|
|
US20070224278A1
(en)
|
2003-11-12 |
2007-09-27 |
Lyons Robert T |
Low immunogenicity corticosteroid compositions
|
|
US20050101582A1
(en)
|
2003-11-12 |
2005-05-12 |
Allergan, Inc. |
Compositions and methods for treating a posterior segment of an eye
|
|
PL1696822T3
(pl)
*
|
2003-11-13 |
2010-08-31 |
Psivida Inc |
Wstrzykiwane implanty o opóźnionym wydzielaniu mające matrycę rdzenia i powłokę podatne na erozję biologiczną
|
|
US7291125B2
(en)
*
|
2003-11-14 |
2007-11-06 |
Transcend Medical, Inc. |
Ocular pressure regulation
|
|
JP2007511507A
(ja)
*
|
2003-11-14 |
2007-05-10 |
ジェンベク、インコーポレイティッド |
癌を処置するための治療レジメン
|
|
CN100558360C
(zh)
*
|
2003-11-20 |
2009-11-11 |
奥特拉控股公司 |
羟胺组合物在制备缓解黄斑变性和其他眼科疾病的药物中的用途
|
|
US20080220049A1
(en)
*
|
2003-12-05 |
2008-09-11 |
Adnexus, A Bristol-Myers Squibb R&D Company |
Compositions and methods for intraocular delivery of fibronectin scaffold domain proteins
|
|
BRPI0417302A
(pt)
|
2003-12-05 |
2007-03-06 |
Compound Therapeutics Inc |
inibidores de receptores de fator de crescimento endotelial vascular do tipo 2
|
|
US7211272B2
(en)
*
|
2003-12-22 |
2007-05-01 |
Bausch & Lomb Incorporated |
Drug delivery device
|
|
EP1706095B1
(de)
|
2004-01-20 |
2008-12-24 |
Allergan, Inc. |
Zusammensetzungen für die lokalisierte therapie des auges, vorzugsweise enthaltend triamcinolon-acetonid und hyaluronsäure
|
|
US20050250788A1
(en)
*
|
2004-01-30 |
2005-11-10 |
Hosheng Tu |
Aqueous outflow enhancement with vasodilated aqueous cavity
|
|
CN1964749A
(zh)
|
2004-04-06 |
2007-05-16 |
苏莫迪克斯公司 |
用于生物活性剂的涂料组合物
|
|
WO2005110492A2
(en)
|
2004-04-12 |
2005-11-24 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Method of using adenoviral vectors to induce an immune response
|
|
US7691381B2
(en)
|
2004-04-15 |
2010-04-06 |
Allergan, Inc. |
Stabilized biodegradable neurotoxin implants
|
|
US20050232972A1
(en)
|
2004-04-15 |
2005-10-20 |
Steven Odrich |
Drug delivery via punctal plug
|
|
WO2005105133A2
(en)
*
|
2004-04-23 |
2005-11-10 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for preserving the viability of photoreceptor cells
|
|
EP1740239A4
(de)
*
|
2004-04-29 |
2008-12-03 |
Iscience Interventional Corp |
Gerät und verfahren für die chirurigsche verstärkung der drainage von wässrigem humor
|
|
US20080058704A1
(en)
*
|
2004-04-29 |
2008-03-06 |
Michael Hee |
Apparatus and Method for Ocular Treatment
|
|
US20050244478A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Anti-excititoxic sustained release intraocular implants and related methods
|
|
US20050244471A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Estradiol derivative and estratopone containing sustained release intraocular implants and related methods
|
|
US20050244465A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Drug delivery systems and methods for treatment of an eye
|
|
US20050244463A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Sustained release intraocular implants and methods for treating ocular vasculopathies
|
|
US7799336B2
(en)
|
2004-04-30 |
2010-09-21 |
Allergan, Inc. |
Hypotensive lipid-containing biodegradable intraocular implants and related methods
|
|
US9498457B2
(en)
|
2004-04-30 |
2016-11-22 |
Allergan, Inc. |
Hypotensive prostamide-containing biodegradable intraocular implants and related implants
|
|
US8591885B2
(en)
*
|
2004-04-30 |
2013-11-26 |
Allergan, Inc. |
Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems
|
|
US7993634B2
(en)
|
2004-04-30 |
2011-08-09 |
Allergan, Inc. |
Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
|
|
US20050244500A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Intravitreal implants in conjuction with photodynamic therapy to improve vision
|
|
US8147865B2
(en)
|
2004-04-30 |
2012-04-03 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
|
US7771742B2
(en)
|
2004-04-30 |
2010-08-10 |
Allergan, Inc. |
Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
|
|
US20050244466A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Photodynamic therapy in conjunction with intraocular implants
|
|
US20060182781A1
(en)
*
|
2004-04-30 |
2006-08-17 |
Allergan, Inc. |
Methods for treating ocular conditions with cyclic lipid contraining microparticles
|
|
US8425929B2
(en)
*
|
2004-04-30 |
2013-04-23 |
Allergan, Inc. |
Sustained release intraocular implants and methods for preventing retinal dysfunction
|
|
AU2011213904B2
(en)
*
|
2004-04-30 |
2014-06-05 |
Allergan, Inc. |
Sustained release intraocular implants comprising a beta adrenergic receptor antagonist and methods for treating ocular neuropathies
|
|
US20050244462A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Devices and methods for treating a mammalian eye
|
|
US20070059336A1
(en)
*
|
2004-04-30 |
2007-03-15 |
Allergan, Inc. |
Anti-angiogenic sustained release intraocular implants and related methods
|
|
US20050244461A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Controlled release drug delivery systems and methods for treatment of an eye
|
|
US20060182783A1
(en)
*
|
2004-04-30 |
2006-08-17 |
Allergan, Inc. |
Sustained release intraocular drug delivery systems
|
|
US20050244469A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Extended therapeutic effect ocular implant treatments
|
|
BRPI0510485A
(pt)
|
2004-04-30 |
2007-11-13 |
Allergan Inc |
implantes inibidores de tirosina cinase intravìtreos biodegradáveis
|
|
US8673341B2
(en)
|
2004-04-30 |
2014-03-18 |
Allergan, Inc. |
Intraocular pressure reduction with intracameral bimatoprost implants
|
|
US8529927B2
(en)
*
|
2004-04-30 |
2013-09-10 |
Allergan, Inc. |
Alpha-2 agonist polymeric drug delivery systems
|
|
US20050244472A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Intraocular drug delivery systems containing excipients with reduced toxicity and related methods
|
|
US7589057B2
(en)
|
2004-04-30 |
2009-09-15 |
Allergan, Inc. |
Oil-in-water method for making alpha-2 agonist polymeric drug delivery systems
|
|
US20050244458A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Sustained release intraocular implants and methods for treating ocular neuropathies
|
|
US8685435B2
(en)
|
2004-04-30 |
2014-04-01 |
Allergan, Inc. |
Extended release biodegradable ocular implants
|
|
US20070212395A1
(en)
*
|
2006-03-08 |
2007-09-13 |
Allergan, Inc. |
Ocular therapy using sirtuin-activating agents
|
|
US8119154B2
(en)
|
2004-04-30 |
2012-02-21 |
Allergan, Inc. |
Sustained release intraocular implants and related methods
|
|
US8722097B2
(en)
|
2004-04-30 |
2014-05-13 |
Allergan, Inc. |
Oil-in-water method for making polymeric implants containing a hypotensive lipid
|
|
CA2572223C
(en)
|
2004-06-25 |
2014-08-12 |
The Johns Hopkins University |
Angiogenesis inhibitors
|
|
AU2005269988B2
(en)
|
2004-07-02 |
2012-02-02 |
Mati Therapeutics Inc. |
Treatment medium delivery device and methods for delivery
|
|
WO2006014484A2
(en)
*
|
2004-07-02 |
2006-02-09 |
Surmodics, Inc. |
Methods and devices for the treatment of ocular conditions
|
|
AU2005271700B2
(en)
*
|
2004-07-12 |
2010-11-11 |
Allergan, Inc. |
Opthalmic compositions and methods for treating ophthalmic conditions
|
|
EP2397490B1
(de)
|
2004-07-16 |
2013-09-04 |
THE UNITED STATES OF AMERICA, represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Impfstoffkonstrukte und Impfstoffkombinationen zur Verbesserung der Breite der Immunantwort auf verschiedene HIV-Stränge und -Clades
|
|
US7117870B2
(en)
*
|
2004-07-26 |
2006-10-10 |
Clarity Corporation |
Lacrimal insert having reservoir with controlled release of medication and method of manufacturing the same
|
|
ES2432556T3
(es)
|
2004-08-04 |
2013-12-04 |
Evonik Corporation |
Métodos para fabricar dispositivos de suministro y sus dispositivos
|
|
US7722669B2
(en)
|
2004-08-13 |
2010-05-25 |
Richard Foulkes |
Method and insert for modifying eye color
|
|
US8246569B1
(en)
|
2004-08-17 |
2012-08-21 |
California Institute Of Technology |
Implantable intraocular pressure drain
|
|
US20060047250A1
(en)
*
|
2004-08-30 |
2006-03-02 |
Hickingbotham Dyson W |
Fluid delivery device
|
|
WO2006039045A2
(en)
*
|
2004-09-01 |
2006-04-13 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Adenoviral vectors able to transduce apcs, potential use in immune response generation
|
|
CN100428958C
(zh)
*
|
2004-09-06 |
2008-10-29 |
段亚东 |
一种治疗眼病的植入剂
|
|
US9993558B2
(en)
|
2004-10-01 |
2018-06-12 |
Ramscor, Inc. |
Sustained release eye drop formulations
|
|
MX2007003968A
(es)
*
|
2004-10-01 |
2008-03-04 |
Ramscor Inc |
Composiciones de farmaco de liberacion sostenida convenientemente implantables.
|
|
US8541413B2
(en)
*
|
2004-10-01 |
2013-09-24 |
Ramscor, Inc. |
Sustained release eye drop formulations
|
|
US20080038316A1
(en)
*
|
2004-10-01 |
2008-02-14 |
Wong Vernon G |
Conveniently implantable sustained release drug compositions
|
|
WO2006043965A1
(en)
*
|
2004-10-14 |
2006-04-27 |
Allergan, Inc. |
Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
|
|
US7226435B2
(en)
*
|
2004-10-14 |
2007-06-05 |
Alcon, Inc. |
Drug delivery device
|
|
US20060089590A1
(en)
*
|
2004-10-27 |
2006-04-27 |
John Higuchi |
Methods and devices for sustained in-vivo release of an active agent
|
|
US20060107555A1
(en)
*
|
2004-11-09 |
2006-05-25 |
Curtis Marc D |
Universal snow plow adapter
|
|
US8663639B2
(en)
|
2005-02-09 |
2014-03-04 |
Santen Pharmaceutical Co., Ltd. |
Formulations for treating ocular diseases and conditions
|
|
CA2597590A1
(en)
|
2005-02-09 |
2006-08-17 |
Macusight, Inc. |
Formulations for ocular treatment
|
|
US7785291B2
(en)
*
|
2005-03-01 |
2010-08-31 |
Tulip Medical Ltd. |
Bioerodible self-deployable intragastric implants
|
|
US7699863B2
(en)
*
|
2005-03-01 |
2010-04-20 |
Tulip Medical Ltd. |
Bioerodible self-deployable intragastric implants
|
|
US20060204548A1
(en)
*
|
2005-03-01 |
2006-09-14 |
Allergan, Inc. |
Microimplants for ocular administration
|
|
US20060233858A1
(en)
*
|
2005-03-08 |
2006-10-19 |
Allergan, Inc. |
Systems and methods providing targeted intraocular drug delivery
|
|
WO2006099288A2
(en)
*
|
2005-03-11 |
2006-09-21 |
Indevus Pharmaceuticals, Inc. |
Controlled release formulations of octreotide
|
|
US7759312B2
(en)
*
|
2005-03-11 |
2010-07-20 |
Endo Pharmaceuticals Solutions Inc. |
Delivery of dry formulations of octreotide
|
|
CA2602525A1
(en)
*
|
2005-03-21 |
2006-09-28 |
Macusight, Inc. |
Drug delivery systems for treatment of diseases or conditions
|
|
US7931909B2
(en)
*
|
2005-05-10 |
2011-04-26 |
Allergan, Inc. |
Ocular therapy using alpha-2 adrenergic receptor compounds having enhanced anterior clearance rates
|
|
US20060258994A1
(en)
*
|
2005-05-12 |
2006-11-16 |
Avery Robert L |
Implantable delivery device for administering pharmacological agents to an internal portion of a body
|
|
US20080312283A1
(en)
*
|
2005-05-26 |
2008-12-18 |
Othera Pharmaceuticals, Inc. |
Use of Hydroxylamine Derivates for Inhibiting Vitrectomy-Induced Cataracts
|
|
US20070021762A1
(en)
*
|
2005-07-13 |
2007-01-25 |
Qing Liu |
Ocular plug formed from placenta derived collagen biofabric
|
|
EA200800338A1
(ru)
*
|
2005-07-15 |
2008-08-29 |
Чакшу Рисерч Инк. |
Профилактика и лечение офтальмологических осложнений диабета
|
|
CN101267779A
(zh)
|
2005-07-27 |
2008-09-17 |
福罗里达大学研究基金会有限公司 |
使用热休克治疗眼睛疾病
|
|
WO2007019427A2
(en)
*
|
2005-08-08 |
2007-02-15 |
Massachusetts Eye & Ear Infirmary |
Methods and compositions for preserving the viability of photoreceptor cells
|
|
US20070060887A1
(en)
*
|
2005-08-22 |
2007-03-15 |
Marsh David A |
Ophthalmic injector
|
|
US8765146B2
(en)
*
|
2005-08-31 |
2014-07-01 |
Genvec, Inc. |
Adenoviral vector-based malaria vaccines
|
|
JP5122460B2
(ja)
*
|
2005-09-16 |
2013-01-16 |
アラーガン、インコーポレイテッド |
治療薬の眼内輸送のための組成物および方法
|
|
US8168584B2
(en)
|
2005-10-08 |
2012-05-01 |
Potentia Pharmaceuticals, Inc. |
Methods of treating age-related macular degeneration by compstatin and analogs thereof
|
|
MX339797B
(es)
|
2005-10-18 |
2016-06-10 |
Allergan Inc |
Terapia ocular que usa derivados glucocorticoides que penetran selectivamente los tejidos del segmento posterior.
|
|
US9067047B2
(en)
*
|
2005-11-09 |
2015-06-30 |
The Invention Science Fund I, Llc |
Injectable controlled release fluid delivery system
|
|
WO2007059461A2
(en)
*
|
2005-11-10 |
2007-05-24 |
Genvec, Inc. |
Adenoviral vector-based foot-and-mouth disease vaccine
|
|
EP1968594B1
(de)
|
2005-11-29 |
2010-09-29 |
GlaxoSmithKline LLC |
Behandlung von neovaskulären augenerkrankungen, wie z.b. maculadegeneration, angioiden streifen, uveitis und makulaödemen
|
|
PT2526910E
(pt)
|
2006-01-17 |
2015-11-18 |
Transcend Medical Inc |
Dispositivo para tratamento de glaucoma
|
|
JP5388582B2
(ja)
|
2006-01-17 |
2014-01-15 |
トランセンド・メディカル・インコーポレイテッド |
薬剤投与処置装置
|
|
US7756524B1
(en)
|
2006-01-31 |
2010-07-13 |
Nextel Communications Inc. |
System and method for partially count-based allocation of vocoder resources
|
|
US20070178138A1
(en)
*
|
2006-02-01 |
2007-08-02 |
Allergan, Inc. |
Biodegradable non-opthalmic implants and related methods
|
|
ES2385924T3
(es)
|
2006-02-02 |
2012-08-03 |
Allergan, Inc. |
Inhibidores de la actividad de CXCR4 para su uso en el tratamiento de trastornos oculares
|
|
KR101478164B1
(ko)
|
2006-02-09 |
2014-12-31 |
산텐 세이야꾸 가부시키가이샤 |
안정한 제제와 그 제조 및 사용 방법
|
|
US20070202186A1
(en)
*
|
2006-02-22 |
2007-08-30 |
Iscience Interventional Corporation |
Apparatus and formulations for suprachoroidal drug delivery
|
|
US20070203190A1
(en)
*
|
2006-02-22 |
2007-08-30 |
Ghanshyam Patil |
Hydroxylamines and derivatives for the inhibition of complement activation
|
|
US20080140057A1
(en)
*
|
2006-03-09 |
2008-06-12 |
Searete Llc, A Limited Liability Corporation Of State Of The Delaware |
Injectable controlled release fluid delivery system
|
|
EP2316505B1
(de)
|
2006-03-14 |
2017-01-18 |
University Of Southern California |
Mems-Vorrichtung zur Wirkstofffreisetzung
|
|
AU2007230964B2
(en)
|
2006-03-23 |
2012-07-19 |
Santen Pharmaceutical Co., Ltd. |
Formulations and methods for vascular permeability-related diseases or conditions
|
|
KR20090006153A
(ko)
|
2006-03-31 |
2009-01-14 |
큐엘티 플러그 딜리버리, 인코포레이티드 |
비루관계에 대한 약물 전달 방법, 구조, 및 조성물
|
|
US8676293B2
(en)
*
|
2006-04-13 |
2014-03-18 |
Aecc Enterprises Ltd. |
Devices, systems and methods for measuring and evaluating the motion and function of joint structures and associated muscles, determining suitability for orthopedic intervention, and evaluating efficacy of orthopedic intervention
|
|
US20070293807A1
(en)
*
|
2006-05-01 |
2007-12-20 |
Lynch Mary G |
Dual drainage pathway shunt device and method for treating glaucoma
|
|
US20070260203A1
(en)
*
|
2006-05-04 |
2007-11-08 |
Allergan, Inc. |
Vasoactive agent intraocular implant
|
|
US7811252B2
(en)
*
|
2006-05-17 |
2010-10-12 |
Alcon Research, Ltd. |
Dosage control device
|
|
US7674243B2
(en)
*
|
2006-05-17 |
2010-03-09 |
Alcon Inc. |
Ophthalmic injection device using piezoelectric array
|
|
US7862540B2
(en)
*
|
2006-05-17 |
2011-01-04 |
Alcon Research, Ltd. |
Ophthalmic injection device using shape memory alloy
|
|
US20070268340A1
(en)
*
|
2006-05-17 |
2007-11-22 |
Bruno Dacquay |
Ophthalmic Injection System and Method Using Piezoelectric Array
|
|
US20070270750A1
(en)
*
|
2006-05-17 |
2007-11-22 |
Alcon, Inc. |
Drug delivery device
|
|
US20070270768A1
(en)
*
|
2006-05-17 |
2007-11-22 |
Bruno Dacquay |
Mechanical Linkage Mechanism For Ophthalmic Injection Device
|
|
US7887521B2
(en)
*
|
2006-05-17 |
2011-02-15 |
Alcon Research, Ltd. |
Ophthalmic injection system
|
|
US7815603B2
(en)
*
|
2006-05-17 |
2010-10-19 |
Alcon Research, Ltd. |
Ophthalmic injection method
|
|
US8668676B2
(en)
*
|
2006-06-19 |
2014-03-11 |
Allergan, Inc. |
Apparatus and methods for implanting particulate ocular implants
|
|
US8802128B2
(en)
|
2006-06-23 |
2014-08-12 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
|
US20070298073A1
(en)
*
|
2006-06-23 |
2007-12-27 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
|
US8721702B2
(en)
|
2010-11-15 |
2014-05-13 |
Aquesys, Inc. |
Intraocular shunt deployment devices
|
|
US8663303B2
(en)
|
2010-11-15 |
2014-03-04 |
Aquesys, Inc. |
Methods for deploying an intraocular shunt from a deployment device and into an eye
|
|
US20120123316A1
(en)
|
2010-11-15 |
2012-05-17 |
Aquesys, Inc. |
Intraocular shunts for placement in the intra-tenon's space
|
|
US8308701B2
(en)
|
2010-11-15 |
2012-11-13 |
Aquesys, Inc. |
Methods for deploying intraocular shunts
|
|
AU2007269259B2
(en)
|
2006-06-30 |
2012-05-31 |
Aquesys Inc. |
Methods, systems and apparatus for relieving pressure in an organ
|
|
US9095411B2
(en)
|
2010-11-15 |
2015-08-04 |
Aquesys, Inc. |
Devices for deploying intraocular shunts
|
|
US8852256B2
(en)
|
2010-11-15 |
2014-10-07 |
Aquesys, Inc. |
Methods for intraocular shunt placement
|
|
US10085884B2
(en)
|
2006-06-30 |
2018-10-02 |
Aquesys, Inc. |
Intraocular devices
|
|
MX357548B
(es)
|
2006-07-11 |
2018-07-13 |
Refocus Group Inc Star |
Prótesis escleral para tratar presbiopia y otros trastornos del ojo y dispositivos y métodos relacionados.
|
|
US8911496B2
(en)
|
2006-07-11 |
2014-12-16 |
Refocus Group, Inc. |
Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methods
|
|
US9039761B2
(en)
*
|
2006-08-04 |
2015-05-26 |
Allergan, Inc. |
Ocular implant delivery assemblies with distal caps
|
|
WO2008024893A2
(en)
|
2006-08-23 |
2008-02-28 |
Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Derivatives of uric and thiouric acid for oxidative stress-related diseases
|
|
WO2008030958A2
(en)
*
|
2006-09-06 |
2008-03-13 |
Innfocus, Llc |
Apparatus, methods and devices for treatment of ocular disorders
|
|
US20080125712A1
(en)
*
|
2006-09-26 |
2008-05-29 |
Alcon Manufacturing, Ltd. |
Ophthalmic injection system
|
|
US20080097379A1
(en)
*
|
2006-09-26 |
2008-04-24 |
Alcon Manufacturing, Ltd. |
Ophthalmic injection method
|
|
US20080097390A1
(en)
*
|
2006-09-27 |
2008-04-24 |
Alcon Manufacturing, Ltd. |
Spring actuated delivery system
|
|
US20080089923A1
(en)
*
|
2006-09-29 |
2008-04-17 |
Burkstrand Michael J |
Biodegradable ocular implants and methods for treating ocular conditions
|
|
US20080091178A1
(en)
*
|
2006-10-11 |
2008-04-17 |
Sunalp Murad A |
Device and method for medical records storage in the eye
|
|
US20100106083A1
(en)
*
|
2006-10-16 |
2010-04-29 |
Alcon Research, Ltd. |
Method of Operating Ophthalmic Hand Piece with Disposable End
|
|
US20080281292A1
(en)
*
|
2006-10-16 |
2008-11-13 |
Hickingbotham Dyson W |
Retractable Injection Port
|
|
US9022970B2
(en)
*
|
2006-10-16 |
2015-05-05 |
Alcon Research, Ltd. |
Ophthalmic injection device including dosage control device
|
|
JP2010506673A
(ja)
*
|
2006-10-16 |
2010-03-04 |
アルコン リサーチ， リミテッド |
眼科ハンドピース用ユニバーサルリチャージャブル限定的再利用アセンブリ
|
|
US8586556B2
(en)
*
|
2006-11-03 |
2013-11-19 |
Allergan, Inc. |
Methods, compositions and drug delivery systems for intraocular delivery of siRNA molecules
|
|
US8039010B2
(en)
|
2006-11-03 |
2011-10-18 |
Allergan, Inc. |
Sustained release intraocular drug delivery systems comprising a water soluble therapeutic agent and a release modifier
|
|
AU2007319383A1
(en)
|
2006-11-10 |
2008-05-22 |
Glaukos Corporation |
Uveoscleral shunt and methods for implanting same
|
|
US20100034808A1
(en)
*
|
2006-11-21 |
2010-02-11 |
Toru Nakazawa |
Compositions and methods for preserving cells of the eye
|
|
AU2007325838B2
(en)
|
2006-11-22 |
2013-09-19 |
Bristol-Myers Squibb Company |
Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR
|
|
WO2008070479A2
(en)
|
2006-12-01 |
2008-06-12 |
Allergan, Inc. |
Method for determining optimum intraocular locations for drug delivery systems
|
|
US8969415B2
(en)
|
2006-12-01 |
2015-03-03 |
Allergan, Inc. |
Intraocular drug delivery systems
|
|
US20080140024A1
(en)
*
|
2006-12-08 |
2008-06-12 |
Yoseph Yaacobi |
Drug delivery device
|
|
US8846073B2
(en)
|
2006-12-19 |
2014-09-30 |
Allergan, Inc. |
Low temperature processes for making cyclic lipid implants for intraocular use
|
|
US20090092574A1
(en)
|
2006-12-29 |
2009-04-09 |
Scott Richard W |
Ophthalmic And Otic Compositions Of Facially Amphiphilic Polymers And Oligomers And Uses Thereof
|
|
WO2008086386A2
(en)
*
|
2007-01-09 |
2008-07-17 |
Genvec, Inc. |
Adenoviral vector-based malaria vaccines
|
|
JP4957258B2
(ja)
*
|
2007-01-15 |
2012-06-20 |
富士通株式会社 |
歩数計数装置および歩数計数方法
|
|
GB0713463D0
(en)
|
2007-07-11 |
2007-08-22 |
Btg Int Ltd |
Modulators of hypoxia inducible factor-1 and related uses
|
|
US7911053B2
(en)
*
|
2007-04-19 |
2011-03-22 |
Marvell World Trade Ltd. |
Semiconductor packaging with internal wiring bus
|
|
US20080265343A1
(en)
*
|
2007-04-26 |
2008-10-30 |
International Business Machines Corporation |
Field effect transistor with inverted t shaped gate electrode and methods for fabrication thereof
|
|
US8231892B2
(en)
*
|
2007-05-24 |
2012-07-31 |
Allergan, Inc. |
Biodegradable drug delivery system
|
|
EP2178502A2
(de)
*
|
2007-06-21 |
2010-04-28 |
Yale University |
Verzögerte abgabe von arzneimitteln aus biologisch abbaubaren polymer-mikroteilchen
|
|
US20090018512A1
(en)
*
|
2007-07-13 |
2009-01-15 |
Charles Steven T |
Pneumatically-Powered Ophthalmic Injector
|
|
US20090018548A1
(en)
*
|
2007-07-13 |
2009-01-15 |
Charles Steven T |
Pneumatically-Powered Intraocular Lens Injection Device with Removable Cartridge
|
|
JP5328788B2
(ja)
|
2007-07-17 |
2013-10-30 |
トランセンド・メディカル・インコーポレイテッド |
ヒドロゲルの拡張能力を備えた眼内植込み体
|
|
US8968396B2
(en)
|
2007-07-23 |
2015-03-03 |
Powervision, Inc. |
Intraocular lens delivery systems and methods of use
|
|
US7740619B2
(en)
*
|
2007-08-01 |
2010-06-22 |
Alcon Research, Ltd. |
Spring driven ophthalmic injection device with safety actuator lockout feature
|
|
ES2523681T3
(es)
*
|
2007-08-02 |
2014-11-28 |
Refocus Group, Inc. |
Prótesis escleral que tiene varillas transversales para tratar la presbicia y otros trastornos del ojo
|
|
US20090036842A1
(en)
*
|
2007-08-03 |
2009-02-05 |
Raffi Pinedjian |
Consumable Activation Lever For Injection Device
|
|
US7629768B2
(en)
*
|
2007-08-03 |
2009-12-08 |
Alcon Research, Ltd. |
Easy cleaning C-shaped charging base
|
|
US9011361B2
(en)
|
2007-09-07 |
2015-04-21 |
Mati Therapeutics Inc. |
Lacrimal implant detection
|
|
TWI498136B
(zh)
*
|
2007-10-09 |
2015-09-01 |
Alcon Res Ltd |
用於遞送速率及溫度相依性物質至眼睛的注射器及其製備方法
|
|
TWI451862B
(zh)
*
|
2007-10-09 |
2014-09-11 |
Alcon Res Ltd |
用於眼睛注射的熱係數驅動藥丸尺寸
|
|
US20090099481A1
(en)
|
2007-10-10 |
2009-04-16 |
Adam Deitz |
Devices, Systems and Methods for Measuring and Evaluating the Motion and Function of Joints and Associated Muscles
|
|
US9849027B2
(en)
|
2007-11-08 |
2017-12-26 |
Alimera Sciences, Inc. |
Ocular implantation device
|
|
EP2222281B1
(de)
|
2007-12-20 |
2018-12-05 |
Evonik Corporation |
Verfahren zur herstellung von mikropartikeln mit geringer restlösemittelmenge
|
|
EP2242464B2
(de)
|
2007-12-20 |
2017-03-01 |
University Of Southern California |
Vorrichtung zur abgabe von therapeutika
|
|
US20090162417A1
(en)
*
|
2007-12-21 |
2009-06-25 |
Cook Incorporated |
Drug eluting ocular conformer
|
|
WO2009089094A2
(en)
*
|
2008-01-03 |
2009-07-16 |
University Of Southern California |
Implantable drug-delivery devices, and apparatus and methods for refilling the devices
|
|
US8602959B1
(en)
*
|
2010-05-21 |
2013-12-10 |
Robert Park |
Methods and devices for delivery of radiation to the posterior portion of the eye
|
|
EP2247615B1
(de)
|
2008-02-14 |
2014-07-30 |
Bristol-Myers Squibb Company |
Zielgerichtete therapeutika auf der basis von egfr gentechnisch hergestellten proteinen
|
|
US20100152646A1
(en)
*
|
2008-02-29 |
2010-06-17 |
Reshma Girijavallabhan |
Intravitreal injection device and method
|
|
US20090227938A1
(en)
*
|
2008-03-05 |
2009-09-10 |
Insitu Therapeutics, Inc. |
Wound Closure Devices, Methods of Use, and Kits
|
|
US9333297B2
(en)
|
2008-05-08 |
2016-05-10 |
Minipumps, Llc |
Drug-delivery pump with intelligent control
|
|
MX2010012212A
(es)
|
2008-05-08 |
2011-09-27 |
Minipumps Llc |
Dispositivos implantables para suministro de fármacos, y áparato y métodos para llenar los dispositivos.
|
|
CN104353150A
(zh)
*
|
2008-05-08 |
2015-02-18 |
迷你泵有限责任公司 |
可植入泵和用于可植入泵的插管
|
|
US9162024B2
(en)
*
|
2008-05-08 |
2015-10-20 |
Minipumps, Llc |
Drug-delivery pumps and methods of manufacture
|
|
JP5591226B2
(ja)
|
2008-05-12 |
2014-09-17 |
ユニバーシティ・オブ・ユタ・リサーチ・ファウンデイション |
眼内薬物送達装置および関連する方法
|
|
US9877973B2
(en)
|
2008-05-12 |
2018-01-30 |
University Of Utah Research Foundation |
Intraocular drug delivery device and associated methods
|
|
US10064819B2
(en)
|
2008-05-12 |
2018-09-04 |
University Of Utah Research Foundation |
Intraocular drug delivery device and associated methods
|
|
US9095404B2
(en)
|
2008-05-12 |
2015-08-04 |
University Of Utah Research Foundation |
Intraocular drug delivery device and associated methods
|
|
AR071874A1
(es)
|
2008-05-22 |
2010-07-21 |
Bristol Myers Squibb Co |
Proteinas de dominio de armazon basadas en fibronectina multivalentes
|
|
EP3298995A1
(de)
|
2008-06-25 |
2018-03-28 |
Novartis AG |
Augenimplantat mit formänderungsfähigkeiten
|
|
US20100028266A1
(en)
|
2008-08-01 |
2010-02-04 |
Alpha Synergy Development. Inc. |
Composition and methods for treating allergic response
|
|
US12246013B2
(en)
|
2008-08-01 |
2025-03-11 |
Eye Therapies Llc |
Vasoconstriction compositions and methods of use
|
|
EP2334686B1
(de)
|
2008-08-28 |
2019-02-27 |
President and Fellows of Harvard College |
Cortistatin-analoga und ihre synthese
|
|
US20100121441A1
(en)
*
|
2008-11-10 |
2010-05-13 |
Nabil Jabbour |
Surgical implant and method
|
|
US9095506B2
(en)
|
2008-11-17 |
2015-08-04 |
Allergan, Inc. |
Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof
|
|
US8034813B2
(en)
|
2008-11-18 |
2011-10-11 |
Bausch & Lomb Incorporated |
Polymorphs of brimonidine pamoate
|
|
US20120232649A1
(en)
|
2008-11-20 |
2012-09-13 |
Insight Innovations, Llc |
Intraocular Lens Cell Migration Inhibition System
|
|
US9943402B2
(en)
|
2008-11-20 |
2018-04-17 |
Insight Innovations, Llc |
Micropatterned intraocular implant
|
|
US8551167B2
(en)
|
2008-11-20 |
2013-10-08 |
Insight Innovations, Llc |
Intraocular implant cell migration inhibition system
|
|
MX2011005272A
(es)
*
|
2008-11-20 |
2011-06-21 |
Insight Innovations Llc |
Sistema de implante intraocular biocompatible biodegradable.
|
|
TWI496582B
(zh)
|
2008-11-24 |
2015-08-21 |
必治妥美雅史谷比公司 |
雙重專一性之ｅｇｆｒ／ｉｇｆｉｒ結合分子
|
|
US20100158980A1
(en)
|
2008-12-18 |
2010-06-24 |
Casey Kopczynski |
Drug delivery devices for delivery of therapeutic agents
|
|
US8545554B2
(en)
*
|
2009-01-16 |
2013-10-01 |
Allergan, Inc. |
Intraocular injector
|
|
US20100191177A1
(en)
*
|
2009-01-23 |
2010-07-29 |
Iscience Interventional Corporation |
Device for aspirating fluids
|
|
US8425473B2
(en)
|
2009-01-23 |
2013-04-23 |
Iscience Interventional Corporation |
Subretinal access device
|
|
EP2548538B1
(de)
|
2009-01-28 |
2020-04-01 |
Alcon Inc. |
Implantationssysteme für augenimplantate mit steifheitseigenschaften
|
|
US8623395B2
(en)
|
2010-01-29 |
2014-01-07 |
Forsight Vision4, Inc. |
Implantable therapeutic device
|
|
CA2757037C
(en)
|
2009-01-29 |
2019-08-06 |
Forsight Vision4, Inc. |
Posterior segment drug delivery
|
|
US9636255B2
(en)
|
2009-02-13 |
2017-05-02 |
Dose Medical Corporation |
Uveoscleral drug delivery implant and methods for implanting the same
|
|
WO2010096561A1
(en)
|
2009-02-18 |
2010-08-26 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Synthetic hiv/siv gag proteins and uses thereof
|
|
JP5342301B2
(ja)
*
|
2009-03-30 |
2013-11-13 |
三菱重工業株式会社 |
太陽光集光受熱器
|
|
US8372036B2
(en)
|
2009-05-06 |
2013-02-12 |
Alcon Research, Ltd. |
Multi-layer heat assembly for a drug delivery device
|
|
USD629503S1
(en)
|
2009-05-08 |
2010-12-21 |
Sean Caffey |
Implantable drug-delivery pump
|
|
JP5937004B2
(ja)
|
2009-05-18 |
2016-06-22 |
ドーズ メディカル コーポレーションＤｏｓｅ Ｍｅｄｉｃａｌ Ｃｏｒｐｏｒａｔｉｏｎ |
薬剤溶出眼内インプラント
|
|
US12478503B2
(en)
|
2009-05-18 |
2025-11-25 |
Glaukos Corporation |
Implants with controlled drug delivery features and methods of using same
|
|
US10206813B2
(en)
|
2009-05-18 |
2019-02-19 |
Dose Medical Corporation |
Implants with controlled drug delivery features and methods of using same
|
|
EP2437684B1
(de)
|
2009-06-03 |
2022-06-15 |
ForSight Vision5, Inc. |
Wirkstofffreisetzung im vorderen augensegment
|
|
IN2012DN00352A
(de)
|
2009-06-16 |
2015-08-21 |
Bikam Pharmaceuticals Inc |
|
|
US8987241B2
(en)
|
2009-06-19 |
2015-03-24 |
Altos Vision Limited |
Time-release and micro-dose formulations for topical application of estrogen and estrogen analogs or other estrogen receptor modulators in the treatment of dry eye syndrome, and methods of preparation and application
|
|
JP5758388B2
(ja)
|
2009-08-18 |
2015-08-05 |
ミニパンプス， エルエルシー |
適応制御を有する電解質薬物送達ポンプ
|
|
US9605844B2
(en)
*
|
2009-09-01 |
2017-03-28 |
Cree, Inc. |
Lighting device with heat dissipation elements
|
|
WO2011038236A2
(en)
|
2009-09-25 |
2011-03-31 |
Ortho Kinematics, Inc. |
Systems and devices for an integrated imaging system with real-time feedback loops and methods therefor
|
|
US20120232102A1
(en)
|
2009-09-30 |
2012-09-13 |
Chun-Fang Xu |
Methods Of Administration And Treatment
|
|
WO2011047316A1
(en)
|
2009-10-16 |
2011-04-21 |
The United States Of America, As Represented By The Secretary Department Of Health And Human Services |
Nucleic acid sequences encoding expandable hiv mosaic proteins
|
|
US20110129516A1
(en)
*
|
2009-10-30 |
2011-06-02 |
Aton Pharma, Inc. |
Ocular drug delivery devices
|
|
NZ716349A
(en)
|
2009-11-09 |
2017-07-28 |
Allergan Inc |
Compositions and methods for stimulating hair growth
|
|
WO2011057254A2
(en)
|
2009-11-09 |
2011-05-12 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Simian adenoviral vector-based vaccines
|
|
EP2498778A1
(de)
|
2009-11-13 |
2012-09-19 |
The United States Of America, As Represented By The Secretary, Department of Health and Human Services |
Diazeniumdiolatverbindungen, pharmazeutische zusammensetzungen und verfahren zur behandlung von krebs
|
|
US8177747B2
(en)
|
2009-12-22 |
2012-05-15 |
Alcon Research, Ltd. |
Method and apparatus for drug delivery
|
|
US8529492B2
(en)
|
2009-12-23 |
2013-09-10 |
Trascend Medical, Inc. |
Drug delivery devices and methods
|
|
US20110238036A1
(en)
*
|
2009-12-23 |
2011-09-29 |
Psivida Us, Inc. |
Sustained release delivery devices
|
|
US10166142B2
(en)
|
2010-01-29 |
2019-01-01 |
Forsight Vision4, Inc. |
Small molecule delivery with implantable therapeutic device
|
|
US8900298B2
(en)
|
2010-02-23 |
2014-12-02 |
Powervision, Inc. |
Fluid for accommodating intraocular lenses
|
|
US9011861B2
(en)
|
2010-02-25 |
2015-04-21 |
Schepens Eye Research Institute |
Therapeutic compositions for the treatment of dry eye disease
|
|
WO2011116189A1
(en)
|
2010-03-17 |
2011-09-22 |
Cornell University |
Disrupted adenovirus-based vaccine against drugs of abuse
|
|
EP2547660B1
(de)
|
2010-03-19 |
2015-01-07 |
The United States Of America, As Represented By The Secretary, Department of Health and Human Services |
Nitroxyl (hno)-freisetzende verbindungen und ihre verwendung zur behandlung von erkrankungen
|
|
US20130137642A1
(en)
|
2010-04-23 |
2013-05-30 |
Demetrios Vavvas |
Methods and compositions for preserving photoreceptor and retinal pigment epithelial cells
|
|
AU2011245117B2
(en)
|
2010-04-30 |
2015-03-12 |
Alexion Pharmaceuticals, Inc. |
Anti-C5a antibodies and methods for using the antibodies
|
|
EP2383286A1
(de)
|
2010-04-30 |
2011-11-02 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Verfahren und Zusammensetzungen zur Behandlung von degenerativen Netzhauterkrankungen
|
|
JP2013526572A
(ja)
*
|
2010-05-17 |
2013-06-24 |
アエリエ・ファーマシューティカルズ・インコーポレーテッド |
眼治療薬の送達のための薬物送達装置
|
|
EP3091028A1
(de)
|
2010-05-26 |
2016-11-09 |
Bristol-Myers Squibb Company |
Auf fibronectin basierende gerüstproteine mit erhöhter stabilität
|
|
WO2012019136A2
(en)
|
2010-08-05 |
2012-02-09 |
Forsight Vision 4, Inc. |
Injector apparatus and method for drug delivery
|
|
PT2600812T
(pt)
*
|
2010-08-05 |
2021-11-09 |
Forsight Vision4 Inc |
Aparelho para tratar um olho
|
|
EP2600876B1
(de)
|
2010-08-05 |
2015-04-29 |
Forsight Vision4, Inc. |
Verfahren und vorrichtung zur verabreichung kombinierter arzneimittel
|
|
WO2012021730A2
(en)
|
2010-08-11 |
2012-02-16 |
Genvec, Inc. |
Respiratory syncytial virus (rsv) vaccine
|
|
WO2012051575A2
(en)
|
2010-10-15 |
2012-04-19 |
Iscience Interventional Corporation |
Device for ocular access
|
|
US20140024598A1
(en)
|
2010-11-01 |
2014-01-23 |
Demetrios Vavvas |
Methods and compositions for preserving retinal ganglion cells
|
|
US10842671B2
(en)
|
2010-11-15 |
2020-11-24 |
Aquesys, Inc. |
Intraocular shunt placement in the suprachoroidal space
|
|
WO2012068549A2
(en)
|
2010-11-19 |
2012-05-24 |
Forsight Vision4, Inc. |
Therapeutic agent formulations for implanted devices
|
|
US9668915B2
(en)
|
2010-11-24 |
2017-06-06 |
Dose Medical Corporation |
Drug eluting ocular implant
|
|
EP2651295A4
(de)
|
2010-12-13 |
2015-11-18 |
Ortho Kinematics Inc |
Verfahren, systeme und vorrichtungen zur berichterstattung über klinische daten und für chirurgische navigation
|
|
WO2012083297A2
(en)
|
2010-12-17 |
2012-06-21 |
Genvec, Inc. |
Adenoviral vectors with modified hexon regions
|
|
WO2012088041A1
(en)
|
2010-12-20 |
2012-06-28 |
Genvec, Inc. |
Adenoviral vector-based dengue fever vaccine
|
|
WO2012114138A1
(fr)
|
2011-02-21 |
2012-08-30 |
Cerebel-Invest Sa |
Implants biodégradables pour la libération contrôlée sous-conjonctivale d'une molécule active
|
|
US10842849B2
(en)
|
2011-02-28 |
2020-11-24 |
The Schepens Eye Research Institute, Inc. |
Methods for promoting neuronal outgrowth by insulin-like growth factor binding protein-like 1 (IGFBPL-1) in glaucoma or leber's optic neuropathy
|
|
US10286146B2
(en)
|
2011-03-14 |
2019-05-14 |
Minipumps, Llc |
Implantable drug pumps and refill devices therefor
|
|
US9919099B2
(en)
|
2011-03-14 |
2018-03-20 |
Minipumps, Llc |
Implantable drug pumps and refill devices therefor
|
|
US9603997B2
(en)
|
2011-03-14 |
2017-03-28 |
Minipumps, Llc |
Implantable drug pumps and refill devices therefor
|
|
EP2691127B1
(de)
|
2011-03-27 |
2021-01-13 |
Microsert Ltd |
Implantierbare miniatur-arzneimittelabgabevorrichtungen und einführsystem zur einführung solcher vorrichtungen
|
|
US9012647B2
(en)
|
2011-04-07 |
2015-04-21 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Nitroxide modified non-steroidal anti-inflammatory compounds and uses thereof in the treatment and prevention of diseases or disorders
|
|
WO2012149452A1
(en)
|
2011-04-29 |
2012-11-01 |
Regents Of The University Of Michigan |
Compounds, formulations, and methods of protein kinase c inhibition
|
|
WO2012162428A1
(en)
|
2011-05-23 |
2012-11-29 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Prime-boost vaccination for viral infection
|
|
CA2837558C
(en)
|
2011-06-02 |
2018-11-20 |
Massachusetts Institute Of Technology |
Modified alginates for cell encapsulation and cell therapy
|
|
US10245178B1
(en)
|
2011-06-07 |
2019-04-02 |
Glaukos Corporation |
Anterior chamber drug-eluting ocular implant
|
|
US9133082B2
(en)
|
2011-06-14 |
2015-09-15 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
|
US20150005254A1
(en)
|
2011-06-27 |
2015-01-01 |
Massachusetts Eye And Ear Infirmary |
Methods for treating ocular inflammatory disorders
|
|
WO2013003620A2
(en)
|
2011-06-28 |
2013-01-03 |
Forsight Vision4, Inc. |
Diagnostic methods and apparatus
|
|
WO2013025840A1
(en)
|
2011-08-15 |
2013-02-21 |
Massachusetts Eye And Ear Infirmary |
Methods for preserving photoreceptor cell viability following retinal detachment
|
|
EP2755549A1
(de)
|
2011-09-13 |
2014-07-23 |
Dose Medical Corporation |
Intraokularer physiologischer sensor
|
|
CA2848397C
(en)
|
2011-09-14 |
2022-04-26 |
Forsight Vision5, Inc. |
Ocular insert apparatus and methods
|
|
ES2864203T3
(es)
|
2011-09-16 |
2021-10-13 |
Forsight Vision4 Inc |
Aparato de intercambio de fluido
|
|
MX2014003993A
(es)
|
2011-10-12 |
2014-08-08 |
Ascendis Pharma Ophthalmology Division As |
Prevencion y tratamiento de condiciones oculares.
|
|
CA2856703A1
(en)
|
2011-10-19 |
2013-04-25 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
|
EP2773341A2
(de)
|
2011-10-21 |
2014-09-10 |
Massachusetts Eye & Ear Infirmary |
Zusammensetzungen mit nekroseinhibitoren wie necrostatinen, allein oder in kombination, zur förderung der axonregeneration und nervenfunktion zur behandlung von zns-erkrankungen
|
|
CA2862807A1
(en)
|
2011-11-30 |
2013-06-06 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
|
WO2013081642A1
(en)
|
2011-12-01 |
2013-06-06 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
|
US9808373B2
(en)
|
2013-06-28 |
2017-11-07 |
Aquesys, Inc. |
Intraocular shunt implantation
|
|
US9610195B2
(en)
|
2013-02-27 |
2017-04-04 |
Aquesys, Inc. |
Intraocular shunt implantation methods and devices
|
|
US8765210B2
(en)
|
2011-12-08 |
2014-07-01 |
Aquesys, Inc. |
Systems and methods for making gelatin shunts
|
|
US8852136B2
(en)
|
2011-12-08 |
2014-10-07 |
Aquesys, Inc. |
Methods for placing a shunt into the intra-scleral space
|
|
US10080682B2
(en)
|
2011-12-08 |
2018-09-25 |
Aquesys, Inc. |
Intrascleral shunt placement
|
|
US9241829B2
(en)
*
|
2011-12-20 |
2016-01-26 |
Abbott Medical Optics Inc. |
Implantable intraocular drug delivery apparatus, system and method
|
|
WO2013116061A1
(en)
|
2012-02-03 |
2013-08-08 |
Forsight Vision4, Inc. |
Insertion and removal methods and apparatus for therapeutic devices
|
|
WO2013124477A1
(en)
|
2012-02-24 |
2013-08-29 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and compositions for treatment of retinal degenerative diseases
|
|
WO2013130393A1
(en)
|
2012-02-28 |
2013-09-06 |
Cornell University |
Aav-directed persistent expression of an anti-nicotine antibody gene for smoking cessation
|
|
US10004811B2
(en)
|
2012-04-13 |
2018-06-26 |
Cornell University |
Development of a highly efficient second generation nicotine-conjugate vaccine to treat nicotine addiction
|
|
US10085633B2
(en)
|
2012-04-19 |
2018-10-02 |
Novartis Ag |
Direct visualization system for glaucoma treatment
|
|
US9241832B2
(en)
|
2012-04-24 |
2016-01-26 |
Transcend Medical, Inc. |
Delivery system for ocular implant
|
|
EP2855511B1
(de)
|
2012-05-29 |
2019-07-24 |
GenVec, Inc. |
Impfstoff gegen das herpes-simplex virus
|
|
CA2874824C
(en)
|
2012-06-01 |
2021-10-26 |
Surmodics, Inc. |
Apparatus and methods for coating balloon catheters
|
|
US9827401B2
(en)
|
2012-06-01 |
2017-11-28 |
Surmodics, Inc. |
Apparatus and methods for coating medical devices
|
|
US10507127B2
(en)
|
2012-06-07 |
2019-12-17 |
Epitomee Medical Ltd. |
Expandable device
|
|
EA030047B1
(ru)
|
2012-09-17 |
2018-06-29 |
Новартис Аг |
Система для имплантации в глаз и способ работы системы для имплантации в глаз
|
|
WO2014052518A1
(en)
|
2012-09-27 |
2014-04-03 |
Allergan, Inc. |
Biodegradable drug delivery systems for the sustained release of proteins
|
|
WO2014066775A1
(en)
|
2012-10-26 |
2014-05-01 |
Forsight Vision5, Inc. |
Ophthalmic system for sustained release of drug to eye
|
|
AU2013342275B2
(en)
|
2012-11-08 |
2017-11-09 |
Clearside Biomedical, Inc. |
Methods and devices for the treatment of ocular diseases in human subjects
|
|
US9763829B2
(en)
|
2012-11-14 |
2017-09-19 |
Novartis Ag |
Flow promoting ocular implant
|
|
US10035822B2
(en)
|
2012-11-15 |
2018-07-31 |
Apellis Pharmaceuticals, Inc. |
Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methods
|
|
US10314870B2
(en)
|
2012-12-10 |
2019-06-11 |
Virginia Commonwealth University |
Tropism modified cancer terminator virus (Ad.5/3 CTV;AD.5/3-CTV-M7)
|
|
AU2014214561C1
(en)
|
2013-02-11 |
2019-01-17 |
Mitokinin, Inc. |
Compositions and methods for treating neurodegenerative diseases
|
|
EP2956096A1
(de)
|
2013-02-15 |
2015-12-23 |
Allergan, Inc. |
Implantat mit langzeit-wirkstofffreisetzung
|
|
MY170528A
(en)
|
2013-02-18 |
2019-08-09 |
Vegenics Pty Ltd |
Vegfr-3 ligand binding molecules and uses thereof
|
|
US9125723B2
(en)
|
2013-02-19 |
2015-09-08 |
Aquesys, Inc. |
Adjustable glaucoma implant
|
|
US10159600B2
(en)
|
2013-02-19 |
2018-12-25 |
Aquesys, Inc. |
Adjustable intraocular flow regulation
|
|
WO2014164704A2
(en)
|
2013-03-11 |
2014-10-09 |
The Broad Institute, Inc. |
Compounds and compositions for the treatment of cancer
|
|
US10981961B2
(en)
|
2013-03-11 |
2021-04-20 |
University Of Florida Research Foundation, Incorporated |
Delivery of card protein as therapy for occular inflammation
|
|
US9730638B2
(en)
|
2013-03-13 |
2017-08-15 |
Glaukos Corporation |
Intraocular physiological sensor
|
|
EP2968113B8
(de)
|
2013-03-14 |
2020-10-28 |
Forsight Vision4, Inc. |
Systeme zur verzögerten intraokularen abgabe schwerlöslicher verbindungen aus einem implantat mit einem portabgabesystem
|
|
WO2014152391A1
(en)
|
2013-03-15 |
2014-09-25 |
Apellis Pharmaceuticals, Inc. |
Cell-penetrating compstatin analogs and uses thereof
|
|
US10517759B2
(en)
|
2013-03-15 |
2019-12-31 |
Glaukos Corporation |
Glaucoma stent and methods thereof for glaucoma treatment
|
|
EP2967842B1
(de)
|
2013-03-15 |
2020-11-04 |
Alcon Inc. |
Verfahren zum rekonfigurieren einer intraokularlinse zur abgabe an eine abgabevorrichtung
|
|
US9592151B2
(en)
|
2013-03-15 |
2017-03-14 |
Glaukos Corporation |
Systems and methods for delivering an ocular implant to the suprachoroidal space within an eye
|
|
CN105246438B
(zh)
|
2013-03-28 |
2018-01-26 |
弗赛特影像4股份有限公司 |
用于输送治疗物质的眼科植入物
|
|
US9987163B2
(en)
|
2013-04-16 |
2018-06-05 |
Novartis Ag |
Device for dispensing intraocular substances
|
|
EP2991621B1
(de)
|
2013-05-02 |
2020-12-09 |
Retina Foundation of the Southwest |
Zweischichtiges augenimplantat
|
|
SG10201702674PA
(en)
|
2013-05-03 |
2017-06-29 |
Clearside Biomedical Inc |
Apparatus and methods for ocular injection
|
|
WO2014182635A1
(en)
|
2013-05-08 |
2014-11-13 |
Baldwin Megan E |
Biomarkers for age-related macular degeneration (amd)
|
|
US20160355573A1
(en)
|
2013-09-05 |
2016-12-08 |
Cornell University |
Gene therapy for alzheimer's and other neurodegenerative diseases and conditions
|
|
EP4046628A1
(de)
|
2013-10-31 |
2022-08-24 |
Allergan, Inc. |
Prostamidhaltige intraokulare implantate und verfahren zur verwendung davon
|
|
US10087224B2
(en)
|
2013-11-01 |
2018-10-02 |
Cornell University |
Gene therapy for Alzheimer's and other neurodegenerative diseases and conditions
|
|
CN111218447B
(zh)
|
2013-11-07 |
2024-10-11 |
爱迪塔斯医药有限公司 |
使用统治型gRNA的CRISPR相关方法和组合物
|
|
AU2014350095B9
(en)
|
2013-11-14 |
2019-09-12 |
Eyed Pharma |
Eye device
|
|
MX2016006297A
(es)
|
2013-11-14 |
2016-07-26 |
Aquesys Inc |
Insertador de derivacion intraocular.
|
|
WO2015083171A1
(en)
|
2013-12-05 |
2015-06-11 |
Tulip Medical Ltd. |
Retentive devices and systems for in-situ release of pharmaceutical active agents
|
|
US10010447B2
(en)
|
2013-12-18 |
2018-07-03 |
Novartis Ag |
Systems and methods for subretinal delivery of therapeutic agents
|
|
SG11201605178WA
(en)
|
2013-12-24 |
2016-07-28 |
Harvard College |
Cortistatin analogues and syntheses and uses thereof
|
|
EP3089748A4
(de)
|
2014-01-02 |
2017-09-27 |
Massachusetts Eye & Ear Infirmary |
Behandlung von neovaskularisierung im auge
|
|
WO2015112739A1
(en)
|
2014-01-22 |
2015-07-30 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Compounds and method for treating parp1-deficient cancers
|
|
ES2919024T3
(es)
|
2014-02-11 |
2022-07-21 |
Mitokinin Inc |
Composiciones y procedimientos que utilizan las mismas para el tratamiento de enfermedades neurodegenerativas y mitocondriales
|
|
US11028388B2
(en)
|
2014-03-05 |
2021-06-08 |
Editas Medicine, Inc. |
CRISPR/Cas-related methods and compositions for treating Usher syndrome and retinitis pigmentosa
|
|
NZ711451A
(en)
|
2014-03-07 |
2016-05-27 |
Alexion Pharma Inc |
Anti-c5 antibodies having improved pharmacokinetics
|
|
US9938521B2
(en)
|
2014-03-10 |
2018-04-10 |
Editas Medicine, Inc. |
CRISPR/CAS-related methods and compositions for treating leber's congenital amaurosis 10 (LCA10)
|
|
US11141493B2
(en)
|
2014-03-10 |
2021-10-12 |
Editas Medicine, Inc. |
Compositions and methods for treating CEP290-associated disease
|
|
US11339437B2
(en)
|
2014-03-10 |
2022-05-24 |
Editas Medicine, Inc. |
Compositions and methods for treating CEP290-associated disease
|
|
EP3540061A1
(de)
|
2014-04-02 |
2019-09-18 |
Editas Medicine, Inc. |
Verfahren und zusammensetzungen in zusammenhang mit crispr/cas zur behandlung eines primären offenwinkelglaukoms
|
|
AU2015266850B2
(en)
|
2014-05-29 |
2019-12-05 |
Glaukos Corporation |
Implants with controlled drug delivery features and methods of using same
|
|
MX384889B
(es)
|
2014-07-15 |
2025-03-14 |
Forsight Vision4 Inc |
Dispositivo y metodo de entrega de implante ocular.
|
|
ES3036749T3
(en)
|
2014-08-01 |
2025-09-23 |
Massachusetts Inst Technology |
Modified alginates for anti-fibrotic materials and applications
|
|
KR20170040798A
(ko)
|
2014-08-08 |
2017-04-13 |
포사이트 비젼4, 인크. |
수용체 티로신 키나제 억제제의 안정한 가용성 제제 및 그의 제조 방법
|
|
CN107405306A
(zh)
*
|
2014-09-19 |
2017-11-28 |
奥叙拉尔有限公司 |
眼部药物组合物
|
|
EP3217924B1
(de)
|
2014-11-10 |
2025-07-16 |
ForSight Vision4, Inc. |
Expandierbare wirkstofffreisetzungsvorrichtungen
|
|
FR3028410A1
(fr)
|
2014-11-18 |
2016-05-20 |
Pierre Coulon |
Implant capsulaire multifonctionnel
|
|
JP6878301B2
(ja)
|
2015-04-09 |
2021-05-26 |
コーネル ユニヴァーシティー |
アレルゲンに対する反応を予防するための遺伝子治療
|
|
EP3283004A4
(de)
|
2015-04-13 |
2018-12-05 |
Forsight Vision5, Inc. |
Augeneinsatzzusammensetzung aus einem semikristallinen oder kristallinen pharmazeutischen wirkstoff
|
|
WO2016182932A1
(en)
|
2015-05-08 |
2016-11-17 |
President And Fellows Of Harvard College |
Cortistatin analogues, syntheses, and uses thereof
|
|
WO2016183297A1
(en)
|
2015-05-12 |
2016-11-17 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Aav isolate and fusion protein comprising nerve growth factor signal peptide and parathyroid hormone
|
|
KR20180014051A
(ko)
|
2015-05-28 |
2018-02-07 |
코넬 유니버시티 |
혈관 부종 치료제로서의 아데노-관련 바이러스 매개 c1e1의 전달
|
|
JP6916742B2
(ja)
|
2015-06-03 |
2021-08-11 |
アクエシス， インコーポレイテッド |
Ａｂ ｅｘｔｅｒｎｏ（眼外から眼内へ）の眼内シャント配置
|
|
US20160354161A1
(en)
|
2015-06-05 |
2016-12-08 |
Ortho Kinematics, Inc. |
Methods for data processing for intra-operative navigation systems
|
|
EP3307206B1
(de)
|
2015-06-10 |
2023-09-20 |
Alcon Inc. |
Materialien und komponenten für intraokularlinsen
|
|
EP3316889A4
(de)
|
2015-07-01 |
2018-11-14 |
President and Fellows of Harvard College |
Cortistatin-analoga sowie synthese und verwendungen davon
|
|
WO2017040853A1
(en)
|
2015-09-02 |
2017-03-09 |
Glaukos Corporation |
Drug delivery implants with bi-directional delivery capacity
|
|
MA43313B1
(fr)
|
2015-09-02 |
2022-06-30 |
Trevena Inc |
Aza-hétérocyclique à 6 éléments contenant des composés modulateurs de récepteurs opioïdes delta, et leurs procédés de fabrication et d'utilisation
|
|
US10182939B2
(en)
|
2015-09-16 |
2019-01-22 |
Novartis Ag |
Hydraulic injector and methods for intra-ocular lens insertion
|
|
US11564833B2
(en)
|
2015-09-25 |
2023-01-31 |
Glaukos Corporation |
Punctal implants with controlled drug delivery features and methods of using same
|
|
KR20180090785A
(ko)
|
2015-10-07 |
2018-08-13 |
아펠리스 파마슈티컬스 인코포레이티드 |
투여 요법
|
|
CN109312338B
(zh)
|
2015-10-30 |
2022-09-27 |
爱迪塔斯医药公司 |
治疗单纯疱疹病毒的crispr/cas相关方法及组合物
|
|
ES2978718T3
(es)
|
2015-11-01 |
2024-09-18 |
Massachusetts Inst Technology |
Alginatos modificados para materiales antifibróticos y aplicaciones
|
|
CA3003738C
(en)
*
|
2015-11-01 |
2021-01-12 |
Massachusetts Institute Of Technology |
Materials with improved properties
|
|
WO2017082946A1
(en)
|
2015-11-13 |
2017-05-18 |
University Of Utah Research Foundation |
Combinatorial gene construct and non-viral delivery for anti-obesity
|
|
KR20180084104A
(ko)
|
2015-11-20 |
2018-07-24 |
포사이트 비젼4, 인크. |
연장 방출 약물 전달 장치를 위한 다공성 구조물
|
|
US10390901B2
(en)
|
2016-02-10 |
2019-08-27 |
Clearside Biomedical, Inc. |
Ocular injection kit, packaging, and methods of use
|
|
AU2017221441A1
(en)
|
2016-02-17 |
2018-10-04 |
Children's Medical Center Corporation |
FFA1 (GPR40) as a therapeutic target for neural angiogenesis diseases or disorders
|
|
WO2017173327A1
(en)
|
2016-03-31 |
2017-10-05 |
The Schepens Eye Research Institute, Inc. |
Endomucin inhibitor as an anti-angiogenic agent
|
|
US11617680B2
(en)
|
2016-04-05 |
2023-04-04 |
Forsight Vision4, Inc. |
Implantable ocular drug delivery devices
|
|
CA3022830A1
(en)
|
2016-04-20 |
2017-10-26 |
Harold Alexander Heitzmann |
Bioresorbable ocular drug delivery device
|
|
JP2019514581A
(ja)
|
2016-05-02 |
2019-06-06 |
クリアサイド バイオメディカル，インコーポレイテッド |
眼の薬物送達のためのシステムおよび方法
|
|
US10501744B2
(en)
|
2016-05-04 |
2019-12-10 |
Indiana University Research And Technology Corporation |
Presentation of bioactive proteins
|
|
CA3024618A1
(en)
|
2016-05-27 |
2017-11-30 |
Alexion Pharmaceuticals, Inc. |
Methods for treatment of refractory generalized myasthenia gravis
|
|
BR112018074389A2
(pt)
|
2016-06-02 |
2019-03-06 |
Aquesys, Inc. |
envio de fármaco intraocular
|
|
CA3027200A1
(en)
|
2016-06-13 |
2017-12-21 |
Massachusetts Institute Of Technology |
Biocompatible zwitterionic polymer coatings and hydrogels for reducing foreign body response and fibrosis
|
|
US11566263B2
(en)
|
2016-08-02 |
2023-01-31 |
Editas Medicine, Inc. |
Compositions and methods for treating CEP290 associated disease
|
|
US10973681B2
(en)
|
2016-08-12 |
2021-04-13 |
Clearside Biomedical, Inc. |
Devices and methods for adjusting the insertion depth of a needle for medicament delivery
|
|
EP3484463B1
(de)
|
2016-08-19 |
2020-02-12 |
The United States of America, as Represented by The Secretary, Department of Health and Human Services Office of Technology Transfer |
Selektive östrogenrezeptormodulatoren (serm) zur verleihung von schutz gegen photorezeptordegeneration
|
|
EP3532616A1
(de)
|
2016-10-28 |
2019-09-04 |
Editas Medicine, Inc. |
Verfahren im zusammenhang mit crispr/cas und zusammensetzungen zur behandlung des herpes-simplex-virus
|
|
WO2018093797A1
(en)
|
2016-11-15 |
2018-05-24 |
The Schepens Eye Research Institute, Inc. |
Compositions and methods for the treatment of aberrant angiogenesis
|
|
WO2018126225A1
(en)
*
|
2016-12-29 |
2018-07-05 |
International Bioceutical Company, Llc |
Modular transdermal delivery system and associated methods of manufacture and use
|
|
CN110520129A
(zh)
|
2017-02-17 |
2019-11-29 |
特维娜有限公司 |
含有5元氮杂杂环的δ阿片受体调节化合物及其使用和制备方法
|
|
CN110446495B
(zh)
|
2017-02-17 |
2023-09-05 |
特维娜有限公司 |
含有7元氮杂杂环的δ阿片受体调节化合物及其使用和制备方法
|
|
US12031144B2
(en)
|
2017-03-29 |
2024-07-09 |
Cornell University |
Oxidation-resistant AAT gene therapy
|
|
BR112019020955A2
(pt)
|
2017-04-07 |
2020-05-05 |
Apellis Pharmaceuticals, Inc. |
regimes de dosagem e composições e métodos relacionados
|
|
WO2018204515A1
(en)
|
2017-05-02 |
2018-11-08 |
Georgia Tech Research Corporation |
Targeted drug delivery methods using a microneedle
|
|
KR102872720B1
(ko)
|
2017-05-05 |
2025-10-16 |
유니버시티 오브 피츠버그 - 오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 |
기질 결합 소낭의 안구에의 적용
|
|
CA3065474A1
(en)
*
|
2017-05-30 |
2018-12-06 |
Eximore Ltd. |
Compositions and methods for treating dry eye syndrome delivering antibiotic macrolide
|
|
WO2018237145A1
(en)
|
2017-06-21 |
2018-12-27 |
Mitokinin, Inc. |
Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease
|
|
US11220544B2
(en)
|
2017-07-14 |
2022-01-11 |
Cytomx Therapeutics, Inc. |
Anti-CD166 antibodies and uses thereof
|
|
ES2965486T3
(es)
|
2017-07-27 |
2024-04-15 |
Alexion Pharma Inc |
Formulaciones de anticuerpos anti-C5 de alta concentración
|
|
CN111372598A
(zh)
|
2017-08-11 |
2020-07-03 |
联合生物科技公司 |
使用消除衰老细胞的药剂治疗诸如黄斑变性,青光眼,和糖尿病性视网膜病变等眼科状况
|
|
US12025615B2
(en)
|
2017-09-15 |
2024-07-02 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Methods of classifying response to immunotherapy for cancer
|
|
KR102907044B1
(ko)
|
2017-10-02 |
2026-01-02 |
진에딧 인코포레이티드 |
변형된 cpf1 가이드 rna
|
|
US11260048B2
(en)
|
2017-10-03 |
2022-03-01 |
The Schepens Eye Research Institute, Inc. |
Compounds and compositions for inhibiting retinal pigment epithelium degeneration and methods using the same
|
|
US12576130B2
(en)
|
2017-10-18 |
2026-03-17 |
Washington University |
Dominant negative SARM1 molecules comprising a substitution at position 189, 190, 193, 194, 570 and/or 685 of SARM1
|
|
JP7518764B2
(ja)
|
2017-10-26 |
2024-07-18 |
アレクシオン ファーマシューティカルズ， インコーポレイテッド |
発作性夜間ヘモグロビン尿症（ＰＮＨ）および非典型溶血性尿毒症症候群（ａＨＵＳ）の処置のための抗Ｃ５抗体の投薬量および投与
|
|
US11318231B2
(en)
|
2017-11-06 |
2022-05-03 |
Massachusetts Institute Of Technology |
Anti-inflammatory coatings to improve biocompatibility of neurological implants
|
|
US11246753B2
(en)
|
2017-11-08 |
2022-02-15 |
Aquesys, Inc. |
Manually adjustable intraocular flow regulation
|
|
CA3082643A1
(en)
|
2017-11-14 |
2019-05-23 |
The Schepens Eye Research Institute, Inc. |
Runx1 inhibition for treatment of proliferative vitreoretinopathy and conditions associated with epithelial to mesenchymal transition
|
|
CN115607358A
(zh)
|
2017-11-21 |
2023-01-17 |
弗赛特影像4股份有限公司 |
用于可扩展端口递送系统的流体交换装置及使用方法
|
|
JP2021507884A
(ja)
|
2017-12-15 |
2021-02-25 |
アペリス・ファーマシューティカルズ・インコーポレイテッドＡｐｅｌｌｉｓ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． |
投与レジメンならびに関連組成物および方法
|
|
CA3087063A1
(en)
|
2017-12-29 |
2019-07-04 |
Cornell University |
Gene therapy for eosinophilic disorders
|
|
US12305185B2
(en)
|
2018-01-23 |
2025-05-20 |
Mount Spec Investments Pty Ltd |
Expression vector and method
|
|
WO2019161378A1
(en)
|
2018-02-19 |
2019-08-22 |
University Of Miami |
Cyclophosphamide for treating ophthalmic inflammation
|
|
EP3758736B1
(de)
|
2018-03-02 |
2024-05-01 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Il-34 zur anwendung in einem verfahren zur behandlung von retinaler entzündung und neurodegeneration
|
|
US10952898B2
(en)
|
2018-03-09 |
2021-03-23 |
Aquesys, Inc. |
Intraocular shunt inserter
|
|
US11135089B2
(en)
|
2018-03-09 |
2021-10-05 |
Aquesys, Inc. |
Intraocular shunt inserter
|
|
DE102018106217A1
(de)
|
2018-03-16 |
2019-09-19 |
Amw Gmbh |
Applikator
|
|
US20210381002A1
(en)
|
2018-04-03 |
2021-12-09 |
Cornell University |
Gene therapy for oxidative stress
|
|
US11821009B2
(en)
|
2018-05-15 |
2023-11-21 |
Cornell University |
Genetic modification of the AAV capsid resulting in altered tropism and enhanced vector delivery
|
|
EP3802593B1
(de)
|
2018-05-31 |
2024-09-11 |
Alexion Pharmaceuticals, Inc. |
Dosierung und verabreichung von anti-c5 antikörpern zur behandlung von paroxysalen nocturalen hämoglobin-uria (pnh) in pädiatrischen patienten
|
|
EP3802603A1
(de)
|
2018-06-04 |
2021-04-14 |
Alexion Pharmaceuticals, Inc. |
Dosierung und verabreichung von anti-c5-antikörpern zur behandlung des atypischen hämolytisch-urämischen syndroms (ahus) bei kindern
|
|
JP7538723B2
(ja)
|
2018-06-28 |
2024-08-22 |
アレクシオン ファーマシューティカルズ， インコーポレイテッド |
抗ｃ５抗体の産生方法
|
|
BR112021001878A2
(pt)
|
2018-07-31 |
2021-04-27 |
Cornell University |
métodos de terapia genética para o controle da função do órgão
|
|
US12240893B2
(en)
|
2018-10-30 |
2025-03-04 |
Alexion Pharmaceuticals, Inc. |
Subcutaneous dosage and administration of anti-C5 antibodies for treatment of paroxysmal nocturnal hemoglobinuria (PNH)
|
|
WO2020112816A1
(en)
|
2018-11-29 |
2020-06-04 |
Surmodics, Inc. |
Apparatus and methods for coating medical devices
|
|
KR20250116790A
(ko)
|
2018-12-12 |
2025-08-01 |
카이트 파마 인코포레이티드 |
키메라 항원 수용체 및 car-t 세포 및 사용 방법
|
|
US20220133768A1
(en)
|
2019-02-25 |
2022-05-05 |
Editas Medicine, Inc. |
Crispr/rna-guided nuclease-related methods and compositions for treating rho-associated autosomal-dominant retinitis pigmentosa (adrp)
|
|
US11819590B2
(en)
|
2019-05-13 |
2023-11-21 |
Surmodics, Inc. |
Apparatus and methods for coating medical devices
|
|
CA3144406A1
(en)
|
2019-06-27 |
2020-12-30 |
Layerbio, Inc. |
Ocular device delivery methods and systems
|
|
EP4007609A1
(de)
|
2019-08-01 |
2022-06-08 |
Cornell University |
Gezielte gentherapie zur behandlung von neurologischen erkrankungen
|
|
WO2021062012A1
(en)
|
2019-09-25 |
2021-04-01 |
Emory University |
Use of klk10 and engineered derivatizations thereof
|
|
EP4038222A4
(de)
|
2019-10-02 |
2023-10-18 |
Arizona Board of Regents on behalf of Arizona State University |
Verfahren und zusammensetzungen zur identifizierung von neoantigenen zur verwendung bei der behandlung und vorbeugung von krebs
|
|
JP2022552375A
(ja)
|
2019-10-15 |
2022-12-15 |
コーネル・ユニバーシティー |
遺伝子治療発現カセットからの発現レベルを調節するための方法
|
|
US11471426B2
(en)
|
2019-10-16 |
2022-10-18 |
American River Nutrition, Llc |
Compositions comprising quinone and/or quinol and methods of preparations and use thereof
|
|
JP2023500793A
(ja)
|
2019-10-16 |
2023-01-11 |
コーネル・ユニバーシティー |
アルツハイマー病に対する遺伝子治療方法
|
|
US20230001017A1
(en)
|
2019-10-28 |
2023-01-05 |
University Of Lowa Research Foundation |
Formulation for delivery of lubricin gene
|
|
KR20220107243A
(ko)
|
2019-11-25 |
2022-08-02 |
코넬 유니버시티 |
Apoe 유전자 요법
|
|
KR20220125326A
(ko)
|
2020-01-09 |
2022-09-14 |
디스크 메디슨, 인크. |
적혈구형성 프로토포르피린증, x-연계된 프로토포르피린증, 또는 선천성 적혈구 조혈포르피린증을 글리신 운반 억제제로 치료하는 방법
|
|
WO2021146625A1
(en)
|
2020-01-17 |
2021-07-22 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Gene therapy for treatment of crx-autosomal dominant retinopathies
|
|
US12678440B2
(en)
|
2020-02-26 |
2026-07-14 |
Case Western Reserve University |
Compositions and methods for treating misfolded protein ocular disorders
|
|
CA3176130A1
(en)
|
2020-03-20 |
2021-09-23 |
Athanor Biosciences, Inc. |
Bacteriophage-based vaccines and engineered bacteriophage
|
|
CA3179541A1
(en)
|
2020-04-05 |
2021-10-14 |
Athanor Biosciences, Inc. |
Bacteriophage-based antibodies and protein-based binders
|
|
WO2021217036A1
(en)
|
2020-04-23 |
2021-10-28 |
Salem Aliasger K |
Gper proteolytic targeting chimeras
|
|
WO2021216378A1
(en)
|
2020-04-23 |
2021-10-28 |
The Schepens Eye Research Institute, Inc. |
Methods and materials for treatment of fibrosis
|
|
CA3176425A1
(en)
|
2020-04-24 |
2021-10-28 |
Millennium Pharmaceuticals, Inc. |
Anti-cd19 antibodies and uses thereof
|
|
EP4149401A4
(de)
|
2020-05-15 |
2024-02-14 |
Eyeflow, Inc. |
Verfahren und vorrichtung zum implantat im herkömmlichen kammerwasserabflussweg eines auges eines säugetiers
|
|
CN116194478A
(zh)
|
2020-06-24 |
2023-05-30 |
阿雷克森制药公司 |
皮下（sc）施用抗c5抗体治疗补体相关病症
|
|
EP4175636A2
(de)
|
2020-07-02 |
2023-05-10 |
The United States of America, as represented by the Secretary, Department of Health and Human Services |
Cyclische verbindungen zur verwendung bei der behandlung von netzhautdegeneration
|
|
WO2022011099A1
(en)
|
2020-07-08 |
2022-01-13 |
Regents Of The University Of Minnesota |
Modified hexosaminidase and uses thereof
|
|
WO2022036104A1
(en)
|
2020-08-12 |
2022-02-17 |
University Of Iowa Research Foundation |
Insulin sensitizers for the treatment of diabetes mellitus
|
|
US20230293678A1
(en)
|
2020-08-21 |
2023-09-21 |
Aliasger K. Salem |
Cationic nanoparticle adjuvants
|
|
US20230414787A1
(en)
|
2020-08-27 |
2023-12-28 |
University Of Iowa Research Foundation |
Gene knock-out for treatment of glaucoma
|
|
CN116406268A
(zh)
|
2020-10-27 |
2023-07-07 |
特维娜有限公司 |
δ-阿片样物质调节剂的结晶和无定形形式
|
|
WO2022125963A1
(en)
|
2020-12-11 |
2022-06-16 |
University Of Iowa Research Foundation |
Compositions comprising molecules for cystic fibrosis treatment
|
|
US12496612B2
(en)
|
2021-01-08 |
2025-12-16 |
Surmodics, Inc. |
Coating application system and methods for coating rotatable medical devices
|
|
JP7829595B2
(ja)
|
2021-04-09 |
2026-03-13 |
武田薬品工業株式会社 |
補体因子ｄを標的とする抗体及びその使用
|
|
WO2022221741A1
(en)
|
2021-04-16 |
2022-10-20 |
Editas Medicine, Inc. |
Crispr/rna-guided nuclease-related methods and compositions for treating rho-associated autosomal-dominant retinitis pigmentosa (adrp)
|
|
PE20241789A1
(es)
|
2021-04-26 |
2024-09-06 |
Millennium Pharm Inc |
Anticuerpos anti-clec12a y usos de los mismos
|
|
AU2022266583A1
(en)
|
2021-04-26 |
2023-10-19 |
Millennium Pharmaceuticals, Inc. |
Anti-adgre2 antibodies and uses thereof
|
|
WO2022246280A1
(en)
|
2021-05-21 |
2022-11-24 |
University Of Iowa Research Foundation |
Anti-oxidant containing particles and methods of use
|
|
WO2022271951A1
(en)
|
2021-06-23 |
2022-12-29 |
University Of Iowa Research Foundation |
Sustained release formulations comprising a selective androgen receptor modulator
|
|
AU2022308658A1
(en)
|
2021-07-07 |
2023-11-16 |
Genentech, Inc. |
Rod inserter system and methods
|
|
AU2022372894A1
(en)
|
2021-10-20 |
2024-04-18 |
Takeda Pharmaceutical Company Limited |
Compositions targeting bcma and methods of use thereof
|
|
WO2023105417A1
(en)
|
2021-12-06 |
2023-06-15 |
Breye Therapeutics Aps |
Danegaptide formulation for applicatoin in the eye
|
|
US20250073322A1
(en)
|
2021-12-29 |
2025-03-06 |
University Of Lowa Research Foundation |
Cystatin rna compositions for tissue engineering
|
|
USD1033637S1
(en)
|
2022-01-24 |
2024-07-02 |
Forsight Vision4, Inc. |
Fluid exchange device
|
|
US20230233375A1
(en)
*
|
2022-01-24 |
2023-07-27 |
Celanese Eva Performance Polymers Llc |
Implantable Device for Delivery of a Tyrosine Kinase Inhibitor
|
|
WO2023164727A1
(en)
|
2022-02-28 |
2023-08-31 |
University Of Iowa Research Foundation |
A-fabp antibodies for diagnosis and treatment of obesity-associated diseases
|
|
US20230346862A1
(en)
|
2022-05-02 |
2023-11-02 |
Athanor Biosciences, Inc. |
Cancer eradicating - bio-nanoparticles (ce-bnp)
|
|
WO2023215560A1
(en)
|
2022-05-05 |
2023-11-09 |
Atoosa Corporation |
Tumor cell/immune cell multivalent receptor engager – bio-nanoparticle (timre-bnp)
|
|
WO2024196814A1
(en)
|
2023-03-17 |
2024-09-26 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods for treatment of age-related macular degeneration
|
|
WO2024233783A1
(en)
|
2023-05-09 |
2024-11-14 |
Cornell University |
Expression cassette coding for vascular endothelial growth factor
|
|
CN119265241A
(zh)
|
2023-06-30 |
2025-01-07 |
深圳菁童生命科学有限公司 |
一种无相分离转录因子介导启始阶段重编程使细胞年轻化的方法
|
|
KR20260056204A
(ko)
|
2023-08-14 |
2026-04-24 |
보로 테라퓨틱스, 인코포레이티드 |
표적 세포에 대한 골수 세포 활성을 조건부로 촉진시키는 치료용 결합제 및 이의 용도
|
|
WO2025083169A1
(en)
|
2023-10-17 |
2025-04-24 |
Tenpoint Therapeutics Limited |
Combination of a vegf inhibitor and a complement pathway inhibitor for treating ocular disorders
|
|
WO2025171280A1
(en)
|
2024-02-07 |
2025-08-14 |
Gensaic, Inc. |
Compositions for targeted delivery to adipose tissue
|
|
WO2025171234A1
(en)
|
2024-02-07 |
2025-08-14 |
Gensaic, Inc. |
Compositions for targeted delivery to muscle tissue
|
|
WO2025213111A2
(en)
|
2024-04-05 |
2025-10-09 |
Cornell University |
Aav expression of mirna to suppress human apoe mrna
|
|
WO2025213138A1
(en)
|
2024-04-05 |
2025-10-09 |
Editas Medicine, Inc. |
Crispr/rna-guided nuclease related methods and compositions for treating primary open angle glaucoma
|
|
USD1137672S1
(en)
|
2024-08-27 |
2026-07-28 |
Glaukos Corporation |
Drug eluting ocular implant
|